C

Colorado Medical Research Center | Denver, CO

Research site

(Unclaimed)

Location

950 E Harvard Ave., Suite 630, Denver, Colorado, United States of America

Site insights

Top conditions

Top treatments

CTP-543

Glycopyrronium

Ruxolitinib

PEP005

MEDI-507

MOB015B

Imiquimod

CLS006

Deuruxolitinib

Onercept

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 34 total trials

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo.

Active, not recruiting

Non-segmental Vitiligo

Drug: Vehicle Gel

Drug: VYN201 Gel

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Dista...

Active, not recruiting

Onychomycosis

Drug: MOB015B

Drug: Vehicle (Placebo Comparator)

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Active, not recruiting

Alopecia Areata

Drug: CTP-543

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair l...

Enrolling

Alopecia Areata

Drug: Placebo

Drug: Deuruxolitinib